BTS
ARRY

BB&T Securities’s Array Biopharma Inc ARRY Stock Holding History

BB&T Securities’s Portfolio ARRY Stock Details ARRY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-174,800
Closed -$8.1M – 1718
2019
Q2 		$8.1M Sell
174,800
-1,700
-1% -$47.7K 0.07% 314
2019
Q1 		$4.3M Buy
176,500
+1,400
+0.8% +$29.1K 0.04% 409
2018
Q4 		$2.5M Sell
175,100
-17,000
-9% -$258K 0.03% 492
2018
Q3 		$2.92M Buy
192,100
+300
+0.2% +$4.6K 0.03% 512
2018
Q2 		$3.22M Buy
191,800
+1,000
+0.5% +$15.9K 0.03% 477
2018
Q1 		$3.11M Buy
190,800
+17,200
+10% +$276K 0.04% 474
2017
Q4 		$2.22M Hold
173,600
– – 0.03% 508
2017
Q3 		$2.13M Buy
173,600
+14,000
+9% +$130K 0.03% 513
2017
Q2 		$1.33M Buy
+159,600
New +$1.31M 0.02% 633

Other funds holding ARRY

ASN
Advisory Services Network Atlanta, Georgia $8.83B AUM 38.5% 1-Year Est. Return

BB&T Securities's ARRY Position: Q3 2019 in Review

BB&T Securities sold out of Array Biopharma Inc (ARRY) in Q3 2019, closing a stake of 174,800 shares — an estimated $8.1M sold.

BB&T Securities first reported a position in ARRY in Q2 2017 and held it in 9 quarters. The position peaked at $8.1M in Q2 2019. 1 fund tracked by Wall St. Rank holds ARRY as of Q3 2019.

  • BB&T Securities reported no remaining Array Biopharma Inc position as of Q3 2019 after selling out during the quarter.
  • BB&T Securities sold 174,800 Array Biopharma Inc shares in Q3 2019, an estimated $8.1M.
  • BB&T Securities first reported a position in Array Biopharma Inc in Q2 2017 and held it in 9 quarters.
  • BB&T Securities's Array Biopharma Inc position peaked at $8.1M in Q2 2019.
  • 1 fund tracked by Wall St. Rank held Array Biopharma Inc as of Q3 2019.

Based on BB&T Securities's 13F filing for Q3 2019, filed 30 Oct 2019.